Nasdaq: SRPT
Sarepta Therapeutics insiders
The officers, directors and 10% owners of Sarepta Therapeutics, Inc. who hold the most stock, valued at the live SRPT price.
$14.17
SRPT today −$360K (−2.48%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their SRPT stock
- $76.8M
- Market value
- $1.52B
- Held by ranked insiders
- 5.06%
Insiders by value of SRPT holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Richard Barry | Director | 3,233,542 | $45.8M | 3.02% | 2663rd |
| 2 | Douglas S. Ingram | Chief Executive Officer | 929,391 | $13.2M | 0.87% | 6384th |
| 3 | Michael Severino | Chief Executive Officer | 756,104 | $10.7M | 0.71% | 2348th |
| 4 | Michael Chambers | Director | 504,027 | $7.1M | 0.47% | 11243rd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Sarepta Therapeutics; see each profile for the filing.